Endostatin's emerging roles in angiogenesis, lymphangiogenesis, disease, and clinical applications.
about
Matricryptins Network with Matricellular Receptors at the Surface of Endothelial and Tumor CellsBiglycan potentially regulates angiogenesis during fracture repair by altering expression and function of endostatin.Inhibitory effect of endostatin gene therapy combined with phosphorus-32 colloid on tumour growth in Wistar rats.Endostatin Sensitizes p53-Deficient Non-Small Cell Lung Cancer to Genotoxic Chemotherapy by Targeting DNA-PKcs.Role of Hypohalous Acids in Basement Membrane Homeostasis.Investigational drugs for nasopharyngeal carcinoma.Fluorescent chemical probes for accurate tumor diagnosis and targeting therapy.Negative regulators of angiogenesis: important targets for treatment of exudative AMD.Limited versus total epithelial debridement ocular surface injury: Live fluorescence imaging of hemangiogenesis and lymphangiogenesis in Prox1-GFP/Flk1::Myr-mCherry mice.Regulation of spermatogenesis by a local functional axis in the testis: role of the basement membrane-derived noncollagenous 1 domain peptide.Endostatin as a Biomarker of Basement Membrane Degradation.Endostar in combination with postoperative adjuvant chemotherapy prolongs the disease free survival of stage IIIA NSCLC patients with high VEGF expression.How Signaling Molecules Regulate Tumor Microenvironment: Parallels to Wound Repair.Angiogenesis and lymphangiogenesis in corneal transplantation-A review.Changes in serum vascular endothelial growth factor and endostatin concentrations associated with circulating endothelial progenitor cells after acute ischemic stroke.Endostatin reverses immunosuppression of the tumor microenvironment in lung carcinoma.Endostar Combined with Gemcitabine and Cisplatin Chemotherapy for Patients with Metastatic Nasopharyngeal Carcinoma: an Update.Proangiogenic Interactions of Vascular Endothelial MMP14 With VEGF Receptor 1 in VEGFA-Mediated Corneal Angiogenesis.Potential lymphangiogenesis therapies: Learning from current antiangiogenesis therapies-A review.Prox1-GFP/Flt1-DsRed transgenic mice: an animal model for simultaneous live imaging of angiogenesis and lymphangiogenesis.Late neuroprogenitors contribute to normal retinal vascular development in a Hif2a-dependent manner.
P2860
Q26766481-81ED4BF2-4B7E-4FEF-89E5-D31AEB2FB90AQ36923882-651903B6-E082-4578-A391-0768374CAD69Q37626801-644A8229-0CB1-4357-BEB5-F56B1B728AACQ38644204-8CA3D20C-EC28-455D-92A5-6DC77CA5E806Q38665718-91302CAE-C8EA-4720-AE8A-51F88FA6AA59Q38690528-C42E1588-8039-42DA-B785-C3C5C987B390Q39187880-273C0BA5-61C1-45F2-A130-9C03AB90D6BFQ39416208-4E2C9253-5EFE-44C9-AFD7-3FAADDE8274BQ41633824-00CD82D6-FD2C-42DA-868A-402861A89985Q42509515-AE92B1CE-FE15-4706-84FF-2A3DEAC9E47DQ42629571-A0753D2D-9C63-4F9E-AA78-CB21B7E19B31Q45124523-A8D330AF-3A17-4C74-AC91-75FFAA4D9A2AQ47601253-C65CB7B1-F9E6-4A80-B9DA-E7020E9D64EDQ47759308-137DC77B-309E-4153-9D99-6166BD89AA16Q48347982-49CA726E-DD80-474E-989F-578044399CF0Q49622371-73DC0B15-DCF5-44D4-9EFD-09B2A8860292Q50137405-11DD9AD4-300B-4244-B4F9-AD8BA78758A5Q50200835-1142CD19-20A8-4422-9F32-0118485112E8Q50419857-199DF744-7D0E-44FC-946A-03E94CEA8778Q50506414-D4C15082-F09A-424B-B1ED-5466110395FFQ52609121-56375349-60FE-4FD0-B5BB-6DA450F5B19C
P2860
Endostatin's emerging roles in angiogenesis, lymphangiogenesis, disease, and clinical applications.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Endostatin's emerging roles in ...... se, and clinical applications.
@ast
Endostatin's emerging roles in ...... se, and clinical applications.
@en
type
label
Endostatin's emerging roles in ...... se, and clinical applications.
@ast
Endostatin's emerging roles in ...... se, and clinical applications.
@en
prefLabel
Endostatin's emerging roles in ...... se, and clinical applications.
@ast
Endostatin's emerging roles in ...... se, and clinical applications.
@en
P2093
P2860
P50
P1476
Endostatin's emerging roles in ...... ase, and clinical applications
@en
P2093
Dimitri T Azar
Jin-Hong Chang
Mark I Rosenblatt
P2860
P304
P356
10.1016/J.BBAGEN.2015.09.007
P407
P577
2015-09-12T00:00:00Z